72 related articles for article (PubMed ID: 23989669)
1. Refractory IGκ/IRF4-positive DLBCL with CDKN2A/2B deletion.
Chonabayashi K; Tamori S; Taniwaki M; Fujita H; Shimazu Y; Matsui Y; Hishizawa M; Usami K; Takaori-Kondo A
Ann Hematol; 2014 May; 93(5):893-4. PubMed ID: 23989669
[No Abstract] [Full Text] [Related]
2. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of CpG islands in p16 as a prognostic factor for diffuse large B-cell lymphoma in a high-risk group.
Shiozawa E; Takimoto M; Makino R; Adachi D; Saito B; Yamochi-Onizuka T; Yamochi T; Shimozuma J; Maeda T; Kohno Y; Kawakami K; Nakamaki T; Tomoyasu S; Shiokawa A; Ota H
Leuk Res; 2006 Jul; 30(7):859-67. PubMed ID: 16406514
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large B-cell lymphomas.
Guney S; Bertrand P; Jardin F; Ruminy P; Kerckaert JP; Tilly H; Bastard C
Genes Chromosomes Cancer; 2011 Sep; 50(9):715-25. PubMed ID: 21638516
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of p15 gene in diffuse - large B-cell lymphoma: association with less aggressiveness of the disease.
Krajnović M; Jovanović MP; Mihaljević B; Anđelić B; Tarabar O; Knežević-Ušaj S; Krtolica K
Clin Transl Sci; 2014 Oct; 7(5):384-90. PubMed ID: 24815848
[TBL] [Abstract][Full Text] [Related]
6. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.
Kim M; Yim SH; Cho NS; Kang SH; Ko DH; Oh B; Kim TY; Min HJ; She CJ; Kang HJ; Shin HY; Ahn HS; Yoon SS; Kim BK; Shin HR; Han KS; Cho HI; Lee DS
Cancer Genet Cytogenet; 2009 Nov; 195(1):59-65. PubMed ID: 19837270
[TBL] [Abstract][Full Text] [Related]
7. Deletion or methylation of CDKN2A/2B and PVT1 rearrangement occur frequently in highly aggressive B-cell lymphomas harboring 8q24 abnormality.
Tsutsumi Y; Chinen Y; Sakamoto N; Nagoshi H; Nishida K; Kobayashi S; Yokokawa Y; Taki T; Sasaki N; Yamamoto-Sugitani M; Kobayashi T; Matsumoto Y; Horiike S; Kuroda J; Taniwaki M
Leuk Lymphoma; 2013 Dec; 54(12):2760-4. PubMed ID: 23547836
[No Abstract] [Full Text] [Related]
8. Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma.
Sinha S; Chunder N; Mukherjee N; Alam N; Roy A; Roychoudhury S; Kumar Panda C
Ann Surg Oncol; 2008 Apr; 15(4):1070-80. PubMed ID: 18239974
[TBL] [Abstract][Full Text] [Related]
9. Frequent deletion and 5' CpG island methylation of the p16 gene in primary malignant lymphoma of the brain.
Zhang SJ; Endo S; Ichikawa T; Washiyama K; Kumanishi T
Cancer Res; 1998 Mar; 58(6):1231-7. PubMed ID: 9515810
[TBL] [Abstract][Full Text] [Related]
10. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
Weber RG; Hoischen A; Ehrler M; Zipper P; Kaulich K; Blaschke B; Becker AJ; Weber-Mangal S; Jauch A; Radlwimmer B; Schramm J; Wiestler OD; Lichter P; Reifenberger G
Oncogene; 2007 Feb; 26(7):1088-97. PubMed ID: 16909113
[TBL] [Abstract][Full Text] [Related]
11. An unusual presentation of large B-cell lymphoma with interferon regulatory factor 4 gene rearrangement.
Verma A; Epari S; Gujral S; Shet T
Indian J Pathol Microbiol; 2018; 61(2):271-274. PubMed ID: 29676376
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.
Kaune KM; Neumann C; Hallermann C; Haller F; Schön MP; Middel P
Exp Dermatol; 2011 Apr; 20(4):331-5. PubMed ID: 21410763
[TBL] [Abstract][Full Text] [Related]
13. [Deletion of p15 and pl6 genes and overexpression of STK15 gene in primary hepatocellular carcinoma].
Zhao JM; Li FC; Xu XY; Fu BY
Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):202-4. PubMed ID: 15760556
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic significance of CDKN2A/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease.
Nicolae-Cristea AR; Benner MF; Zoutman WH; van Eijk R; Jansen PM; Tensen CP; Willemze R
Br J Dermatol; 2015 Mar; 172(3):784-8. PubMed ID: 25308604
[No Abstract] [Full Text] [Related]
15. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
16. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.
Dreyling MH; Roulston D; Bohlander SK; Vardiman J; Olopade OI
Genes Chromosomes Cancer; 1998 May; 22(1):72-8. PubMed ID: 9591637
[TBL] [Abstract][Full Text] [Related]
17. Methylation and expression analysis of tumor suppressor genes p15 and p16 in benzene poisoning.
Xing C; Wang QF; Li B; Tian H; Ni Y; Yin S; Li G
Chem Biol Interact; 2010 Mar; 184(1-2):306-9. PubMed ID: 20044985
[No Abstract] [Full Text] [Related]
18. Quantitative evaluation of p16(INK4a) promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma.
Zainuddin N; Kanduri M; Berglund M; Lindell M; Amini RM; Roos G; Sundström C; Enblad G; Rosenquist R
Leuk Res; 2011 Apr; 35(4):438-43. PubMed ID: 21035853
[TBL] [Abstract][Full Text] [Related]
19. CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
Iacobucci I; Ferrari A; Lonetti A; Papayannidis C; Paoloni F; Trino S; Storlazzi CT; Ottaviani E; Cattina F; Impera L; Abbenante MC; Vignetti M; Vitale A; Potenza L; Paolini S; Soverini S; Pane F; Luppi M; Foà R; Baccarani M; Martinelli G
Clin Cancer Res; 2011 Dec; 17(23):7413-23. PubMed ID: 22134481
[TBL] [Abstract][Full Text] [Related]
20. IRF4 expression without IRF4 rearrangement is a general feature of primary cutaneous diffuse large B-cell lymphoma, leg type.
Pham-Ledard A; Prochazkova-Carlotti M; Vergier B; Petrella T; Grange F; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 May; 130(5):1470-2. PubMed ID: 20054341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
